Krupp LB - Search Results

1

Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis.

Yeh EA, Waubant E, Krupp LB, Ness J, Chitnis T, Kuntz N, Ramanathan M, Belman A, Chabas D, Gorman MP, Rodriguez M, Rinker JR 2nd, Weinstock-Guttman B; National Network of Pediatric MS Centers of Excellence. Yeh EA, et al. Among authors: krupp lb. Arch Neurol. 2011 Apr;68(4):437-44. doi: 10.1001/archneurol.2010.325. Epub 2010 Dec 13. Arch Neurol. 2011. PMID: 21149803

2

Fatigue in multiple sclerosis.

Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Krupp LB, et al. Arch Neurol. 1988 Apr;45(4):435-7. doi: 10.1001/archneur.1988.00520280085020. Arch Neurol. 1988. PMID: 3355400

3

Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.

Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L, Halper J, Johnson B, Morgante L, Grimson R. Krupp LB, et al. Neurology. 1995 Nov;45(11):1956-61. doi: 10.1212/wnl.45.11.1956. Neurology. 1995. PMID: 7501140 Clinical Trial.

4

Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme disease.

Coyle PK, Schutzer SE, Deng Z, Krupp LB, Belman AL, Benach JL, Luft BJ. Coyle PK, et al. Among authors: krupp lb. Neurology. 1995 Nov;45(11):2010-5. doi: 10.1212/wnl.45.11.2010. Neurology. 1995. PMID: 7501150

5

Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis.

Krupp LB, Sliwinski M, Masur DM, Friedberg F, Coyle PK. Krupp LB, et al. Arch Neurol. 1994 Jul;51(7):705-10. doi: 10.1001/archneur.1994.00540190089021. Arch Neurol. 1994. PMID: 8018045

6

Detection of Borrelia burgdorferi antigens in cerebrospinal fluid.

Coyle PK, Deng Z, Schutzer SE, Belman AL, Benach J, Krupp LB, Luft B. Coyle PK, et al. Among authors: krupp lb. Neurology. 1993 Jun;43(6):1093-8. doi: 10.1212/wnl.43.6.1093. Neurology. 1993. PMID: 8170548

7

The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.

Geisler MW, Sliwinski M, Coyle PK, Masur DM, Doscher C, Krupp LB. Geisler MW, et al. Among authors: krupp lb. Arch Neurol. 1996 Feb;53(2):185-8. doi: 10.1001/archneur.1996.00550020101021. Arch Neurol. 1996. PMID: 8639070 Clinical Trial.

8

A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis.

Miller AE, Morgante LA, Buchwald LY, Nutile SM, Coyle PK, Krupp LB, Doscher CA, Lublin FD, Knobler RL, Trantas F, Kelley L, Smith CR, La Rocca N, Lopez S. Miller AE, et al. Among authors: krupp lb. Neurology. 1997 Feb;48(2):312-4. doi: 10.1212/wnl.48.2.312. Neurology. 1997. PMID: 9040712 Clinical Trial.

9

Are quantitative functional measures more sensitive to worsening MS than traditional measures?

Schwid SR, Goodman AD, Apatoff BR, Coyle PK, Jacobs LD, Krupp LB, Miller AE, Wende KE, Brownscheidle CM, New York State Multiple Sclero. Schwid SR, et al. Among authors: krupp lb. Neurology. 2000 Dec 26;55(12):1901-3. doi: 10.1212/wnl.55.12.1901. Neurology. 2000. PMID: 11134392

10

Symptomatic therapy for underrecognized manifestations of multiple sclerosis.

Krupp LB, Rizvi SA. Krupp LB, et al. Neurology. 2002 Apr 23;58(8 Suppl 4):S32-9. doi: 10.1212/wnl.58.8_suppl_4.s32. Neurology. 2002. PMID: 11971124 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters